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Abstract 
Background and Aims: Nonalcoholic fatty liver disease (NAFLD) and its metabolic risk 
factors are recognized during childhood and adolescence. Identification of adolescents at risk 
of NAFLD from childhood anthropometry may expose opportunities to influence the hepatic 
and metabolic destinies of individuals. We sought associations between NAFLD diagnosed 
during adolescence and earlier life trajectories of anthropometry, in a population-based cohort 
of predominantly Caucasian adolescents.  
Methods: Assessment for NAFLD, using questionnaires and liver ultrasound was performed 
on 1170 adolescents, aged 17 years, from the population-based Raine Cohort. We sought 
associations between NAFLD in adolescents and serial anthropometric measurements 
recorded from birth, childhood and adolescence.  
Results: NAFLD was diagnosed in 15.2% of adolescents. Birth anthropometry, including 
birth weight, skinfold thickness and ponderal index, was not associated with NAFLD. 
However, adiposity differences between 17-year-old adolescents with NAFLD and those 
without NAFLD were apparent from age 3 years. Greater adiposity trajectories for weight, 
body mass index, skinfold thickness, mid-arm circumference and chest circumference from 
age 3 years onwards, particularly in males, were associated with the diagnosis of NAFLD and 
severity of hepatic steatosis at age 17 years (p<0∙05). The strength of the associations 
increased with age after 3 years for each adiposity measure (all p<0∙001).  
Conclusions: Trajectories of childhood adiposity are associated with NAFLD. Adiposity 
attained by three years of age and older, but not at birth, was associated with the diagnosis 
and severity of hepatic steatosis in late adolescence. Exploration of clinically relevant risk 
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Metabolic disorders associated with obesity are increasingly recognized in adults and 
children. Nonalcoholic fatty liver disease (NAFLD) is predominantly diagnosed in adults, 
however adolescent and childhood NAFLD phenotypes share adiposity, dyslipidemia, insulin 
resistance or the metabolic syndrome with adult NAFLD.
1 
Whilst generally considered a 
disease of modern times, detailed clinico-pathologic descriptions of NAFLD are found in the 
medical literature dating back to the 1850s.
2
 With increasing population trends of overweight 
and obesity, NAFLD is now very prevalent in many countries
3
 and may have implications for 
liver, cardiovascular and metabolic health. The histology of NAFLD has been refined during 
the last 40 years.
4-6
. Nonalcoholic steatohepatitis (NASH), the histologically more adverse 
form of NAFLD, is associated with increased risk of cirrhosis, atherosclerotic cardiovascular 
disease
7,8
 and type 2 diabetes.
9
 Several reports describe the spectrum of NAFLD, from plain 
steatosis through NASH and cirrhosis in children and adolescents.
10,11 
Though adults and 
children with NAFLD may share similar metabolic risk factors, NAFLD in children may 
have distinct histopathological characteristics compared with adult NAFLD
12
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The underlying pathogenesis of NAFLD is complex. Although the genetic risk and 
heritability of NAFLD is increasingly described,
14-18
 the influence of intrauterine, postnatal 
and childhood growth, on the diagnosis of NAFLD later in life remains poorly defined. The 
developmental origins of health and disease hypothesis proposes that environmental factors 
during pregnancy and infancy influence the risk of adult disease.
19
 Though low birth weight 
followed by rapid weight gain has been associated with adult insulin resistance and coronary 
events,
20







the influences of postnatal and childhood growth have also been suggested as dominant 
drivers in the development of factors associated with NAFLD, namely cardiovascular risk, 
hypertension, obesity and raised liver enzymes in later life.
23-26
 This observation has been 
extended to body mass index (BMI) at age 17 years conferring risk for coronary artery 
disease in young adults.
27
 Hence adiposity trajectories during childhood and adolescence may 
offer insights into future NAFLD and highlight the appropriate time period for intervention.  
A previously published cross-sectional assessment of 1,170 adolescents aged 17 years in the 
Western Australian Pregnancy (Raine) Cohort reported gender-specific differences in the 
prevalence of the metabolic syndrome, visceral and subcutaneous adipose tissue distribution, 
serum adipocytokine and transaminase levels, insulin resistance and systolic blood pressure 
between those with NAFLD compared with those without NAFLD.
1
 Suprailiac skinfold 
thickness (a measure of subcutaneous adiposity) in both genders and serum alanine 
aminotransferase (ALT) level, in males, predicted NAFLD in adolescents in the Raine cohort. 
Candidate gene and genome-wide association studies of NAFLD in the Raine cohort also 
detected effects of suprailiac skinfold thickness independent of various polymorphisms,
17,18
  
with suprailiac skinfold thickness accounting for a greater improvement in the NAFLD 











This article is protected by copyright. All rights reserved. 
 
The Raine cohort was representative of the Western Australian adolescent population at the 
time of the 17-year assessment
28
 and has well-defined longitudinal characterization. 
Consequently, knowledge of the prospective risk of adolescent NAFLD from anthropometry 
serially measured from birth through adolescence has potential to contribute to the 
understanding of initial pathogenic factors for NAFLD and provide rationale for early 
intervention. Recent commentary has drawn attention to the difficulty of treating adult 
obesity and related conditions such as NAFLD and highlighted the importance of identifying 
the onset of risk for these conditions to enable timely preventative strategies.
29
 Therefore, our 
study aimed to examine and identify associations between anthropometry at different time-
points, adiposity trajectories from birth, through childhood and adolescence and a subsequent 
diagnosis of NAFLD at 17 years of age.   
Subjects and Methods 
Study population 
The Raine Study was initiated as a pregnancy and birth cohort comprising 2,868 
predominantly Caucasian live-born children recruited from King Edward memorial Hospital 
for Women between 1989 and 1992 from 2,900 pregnancies, in Perth, Western Australia. Of 
these, 1170 out of 1754 adolescents participating in the 17-year cross-sectional assessment 
attended ultrasound examination for fatty liver. The background and assessments in serial 




Anthropometric measurements were recorded at birth and serially through childhood and 
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skinfold thickness was not measured at ages 8 and 14 years and waist circumference was only 
available at ages 14 and 17 years. BMI was derived from weight (kg)/ height (m
2
). Ponderal 
index, a measure of leanness,
25




) and percentage 
of expected birth weight defined as the percentage of expected weight adjusted for gestational 
age. Weight (birth, year one) and BMI (all age assessments) were standardised for sex and 
age (age at birth was represented by a single time point) using the WHO Growth Standards 
for ages ≤2 years and using CDC Growth Standards for ages over 2 years.
31,32
. Weight and 
BMI z-scores were calculated and used in analyses. The 17-year cross-sectional assessment 
of the Raine cohort, conducted between July 2006 and June 2009, involved detailed 
questionnaires, anthropometric and cardiovascular examination and liver ultrasound. Serum 
from venous blood samples taken from an antecubital vein after overnight fasting was tested 
for glucose, insulin, ALT, aspartate aminotransferase (AST), gamma-glutamyl transpeptidase 
(GGT), triglyceride, total cholesterol, HDL-C, low-density lipoprotein cholesterol (LDL-C), 
highly sensitive C-reactive protein (CRP), adiponectin, and leptin levels. All laboratory 
assays were performed at an accredited central laboratory (Pathwest Laboratories, Perth, 
Western Australia, Australia) using standard methodologies.
1,23
 Data from the 17-year 
assessment, including the ultrasound methodology for diagnosing fatty liver, subcutaneous 
and visceral adipose thickness have previously been published.
1
 
Diagnosis of NAFLD 
Assessment for NAFLD in the Raine Study was performed for the first time during the 17-
year cross-sectional assessment. The diagnosis of NAFLD was based on ultrasound 
characteristics and exclusion of significant alcohol intake. Ultrasound was used as it was the 
most practical method to screen large numbers of adolescents in a community setting. We 
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100% specificity for the histological diagnosis of > 10% hepatic steatosis.
33
 Information on 
alcohol intake patterns over the previous year was documented by self-reporting and by the 
completion of a validated semiquantitative food frequency questionnaire developed by the 
Commonwealth Scientific and Industrial Research Organisation (Adelaide, Australia).
34
 In 
the current study adolescents with sonographic fatty liver and weekly alcohol intake of less 
than 210 grams and 140 grams for males and females, respectively, were classified as having 
NAFLD, consistent with recent NAFLD diagnosis and management guidelines.
35
 As part of a 
subsequent assessment, subjects underwent noninvasive assessment of liver fibrosis using 
tissue elastography. Participants with a liver stiffness of greater than 8.7 kPa underwent 
standard clinical evaluation, with exclusion of autoimmune, viral or metabolic diseases. 
Institutional ethics committee approval was obtained from the Princess Margaret Hospital for 
Children Human Research Ethics Committee. Signed informed parental consent and 
adolescent assent at 17 years were obtained.  
Statistical Analysis 
Sex-specific analyses were performed to characterize gender differences between adolescents 
diagnosed with or without NAFLD at age 17 years, as previously described in the Raine 
Study (1). Variables were summarized by the mean and standard deviation for symmetrical 
distributions and median and interquartile range (IQR) for asymmetric distributions. Birth 
anthropometry and change in weight z-score between birth and one year were analyzed using 
Student’s t-test. Anthropometry, serum biochemistry and cardiovascular characteristics 
between adolescents with or without NAFLD were compared using the independent t-test or 
Mann-Whitney U-test. Skinfold thicknesses, chest, mid-arm and waist circumference in 
adolescents with or without NAFLD were compared at each available age assessment using 
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severity of hepatic steatosis were analysed using the Kruskal-Wallis test. Skinfold thickness 
was displayed as mean time-response curves for the NAFLD and non-NAFLD groups, with 
confidence limits calculated using a bootstrap technique (5000 repetitions) designed for 
repeated measures. BMI z-scores (adjusted for age and sex) were compared, between 
adolescents with or without NAFLD, using linear mixed effects models for longitudinal data; 
including fixed effects for age and age-squared, random effects for slope and intercept and a 
correlation structure of autoregressive order one. From each age assessment, independent 
predictors of adolescent NAFLD were determined using multivariate logistic regression 
analysis including terms for skinfold thickness, mid-arm circumference, chest circumference 
and BMI z-score. Due to consistency of skinfold thickness between various skinfold regions 
we used only suprailiac skinfold thickness in longitudinal and multivariate analyses, as it 
demonstrated the earliest differences between NAFLD and non-NAFLD groups and has 
previously been found to have the strongest association with NAFLD in this cohort. All 
statistical tests were two-sided and based on a significance level of 5%. No correction was 
made for multiple testing due to the correlated nature of the anthropometric data. Data were 
analyzed using IBM SPSS statistics package (version 20∙0) and R: A language and 
environment for statistical computing (version 2∙11∙1).  
Results 
In the 17-year cross-sectional study abdominal ultrasound was performed on 1170 
adolescents, of whom 1127 had waist circumference measured. After excluding 3 adolescents 
with fatty liver who consumed excessive amounts of alcohol, the prevalence of NAFLD was 
15∙2% (177/1167). NAFLD was more prevalent in females than in males (19∙6% vs. 10∙8%, 
p<0∙001). Central obesity (waist 80 cm in females and waist  94 cm in males) was detected 
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females and 34/56 (60∙7%) of males had NAFLD. Adolescents with NAFLD had a more 
adverse metabolic phenotype than those without NAFLD (Table 1).  
Associations between Birth to Age 1 Year Anthropometry and Adolescent NAFLD 
Birth anthropometry (birth weight z-score, percentage of expected birth weight, ponderal 
index, and all skinfold thickness measurements) was similar in adolescents diagnosed with or 
without NAFLD (all p>0∙05) (Table 2). The change in weight z-score between birth and age 
1 was similar in adolescents with or without NAFLD. Similarly, skinfold thickness, weight, 
crown-heel length and z-BMI at age 1 year were not associated with the diagnosis of NALFD 
(p>0∙05 for all, data not shown). 
Associations between Age Three to Ten Years (Childhood) Anthropometry and 
Adolescent NAFLD 
Adolescents diagnosed with NAFLD at age 17 already had greater pre-existing adiposity, 
particularly BMI z-score, suprailiac skinfold thickness, chest and mid-arm circumference, 
from age 3 years onwards compared with those without NAFLD (Table 2 and Figures 1 and 
2). By age 10 years, median suprailiac skinfold thickness in males who were subsequently 
diagnosed with NAFLD was nearly double that of males who did not have NAFLD (p<0∙001) 
(Figure 1).  
Associations between Ages 14 and 17 Years (Adolescent) Anthropometry and 
Adolescent NAFLD 
By adolescence there were well-established differences in anthropometric features between 
adolescents with or without NAFLD.  Adolescents diagnosed with NAFLD had significantly 
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circumference) compared with those without NAFLD. In particular, median skinfold 
thickness in 17-year old males with NAFLD was twice that of males without NAFLD (Figure 
1). Figure 2 illustrates the strong association between increasing BMI and diagnosis of 
NAFLD from the longitudinal analysis (p<0∙001).   
Childhood Adiposity and Severity of Sonographic Hepatic Steatosis 
Increasing adiposity from age 3 years onwards was associated with increasing sonographic 
severity of liver steatosis at age 17 years  (p<0∙05 at 3 years, p<0∙001 from 5 years onwards 
for suprailiac skinfold thickness; p<0∙001 from 5 years onwards for longitudinal BMI z-score 
in both genders [Figure 3]).    
Relationship between childhood and adolescent suprailiac skinfold thickness and serum 
ALT in adolescents  
Suprailiac skinfold thickness from age 3 years onwards in females and from age 10 years 
onwards in males was associated with raised serum ALT levels (> 30U/L in females, >40U/L 
in males) at age 17 years (all p<0∙05).  
Age-specific Prediction of Adolescent NAFLD  
The strength of association between childhood adiposity and NAFLD risk increased with age. 
Using multivariate logistic regression analysis, adiposity predictors of adolescent NAFLD 
were determined from skinfold thickness, BMI z-score and mid-arm circumference. 
Suprailiac skinfold thickness contributed more to the prediction of NAFLD in adolescents at 
all ages from 3 years onwards compared to the other measures of adiposity, including BMI. 
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for suprailiac skinfold thickness, whereas gender differences were still detected after 
adjustment for BMI z-score. 
Discussion 
In this study, pre-school age childhood anthropometry was associated with a diagnosis of 
NAFLD at age 17 years. Adiposity gains from age 3 years onwards were greater in 
adolescents diagnosed with NAFLD than those without NAFLD. The association of adiposity 
gains with NAFLD was most apparent in males and increased with age, highlighting a critical 
period of childhood when environmental influences (nutrition, physical activity), gene-
environmental interactions and epi-genetic programming may influence the trajectory 
towards obesity-related diseases such as NAFLD.   
In the Raine Cohort, childhood adiposity trajectories have already been shown to be 
associated with adolescent insulin resistance.
30 
Our study examines the genesis of risk factors 
for NAFLD from childhood and adolescent anthropometric characteristics. There are 
presently no longitudinal data regarding the predictive utility of basic childhood 
anthropometry for future NAFLD in adolescence. In this cohort, suprailiac skinfold thickness 
in adolescents aged 17 years independently predicted NAFLD compared to metabolic factors 
and other anthropometry. We have now tracked anthropometric characteristics in the cohort 
starting from birth and observed suprailiac skinfold thickness, as a marker of adiposity from 
as early as age 3 years onwards, to be strongly associated with adolescent NAFLD. A role for 
dietary and physical activity habits is supported by the finding that in the Raine Study the 
Western dietary pattern, lower rates of physical activity and longer television-watching 
duration at age 14 years were associated with NAFLD at age 17 years.
36
 Other data from the 
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cardio-metabolic risk factors at age 17 years.
37
 Also, NAFLD combined with co-existing 
cardio-metabolic risk factors was associated with subclinical cardiovascular disease 
determined by increased arterial stiffness in adolescents in the Raine Study.
38
 These data 
demonstrate that the pathway to NAFLD and associated adverse cardio-metabolic 
characteristics is established in the first few years of life.  Further studies examining the role 
of physical activity, infant and early childhood diet, as well as possible emerging risk factors 
such as gut microbiome diversity, will be important to guide interventions to prevent future 
metabolic disease.   
Though subcutaneous fat is considered less metabolically active, hence less relevant to 
metabolic health than visceral fat, subcutaneous fat measured by skinfold thickness is easy to 
measure in children and adolescents and is positively associated with adolescent NAFLD. (1) 
Visceral adipose mass is much less developed in children, compared with adults, though 
accumulating rapidly with weight gain, particularly in males.
39,40
  The potential importance of  
subcutaneous fat is also reported in the Amsterdam Growth and Health Longitudinal Study, 
in which skinfold thickness was a better predictor of high body fatness in adults than the 
BMI.
41
 Thus both fat compartments may be relevant as markers of future NAFLD at varying 
points in the life spectrum  
Strengths of our study include the prospective collection of quality data based on 
standardized study protocols, the longitudinal nature of the study, duration of follow up and 
previously well-described outcome measures in a population-based cohort. Limitations of this 
study are the single cross-sectional assessment for NAFLD, the use of ultrasound rather than 
histology, magnetic resonance imaging (MRI) or magnetic resonance spectroscopy to 
diagnose and quantify liver fat. Whilst the absence of histology restricts our ability to 
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diabetes or cardiovascular disease relative to general population risk, liver biopsy of healthy 
adolescents in this population-based study is not justifiable. Further, a meta-analysis of the 
diagnostic accuracy and reliability of ultrasound has concluded that it is the imaging 
technique of choice for clinical and population settings, as well as correlating with metabolic 
abnormalities and visceral adiposity.
42,43
 Thus, from a practical clinical translational 
perspective an understanding of the significance of ultrasound-diagnosed NAFLD remains 
relevant.  
In conclusion, the genesis of risk of late adolescent NAFLD begins in the first few years of 
life, with differences in adiposity evident from three years of age. Examination of genetic-
environmental interactions, epi-genetic and metabolic alterations in this critical early period 
of life may shed light on important risk factors for the development of future NAFLD.  
Knowledge that childhood obesity and trajectories of increasing adiposity have potential to 
confer not only increased risk for adverse cardiovascular outcomes but also adverse liver 
outcomes could provide insights for public health education and targeted research and 
interventional studies during childhood and adolescence to ameliorate the risk factors for 
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 Male Female 
Characteristic NAFLD  
(n = 63) 
Non-NAFLD  






 Non-NAFLD  










Weight (kg) 94.5 (20.2) 69.4 (11.0) < 0.001 72.9 (17.2) 60.9 (10.0) < 0.001 
Waist (cm) 97.7 (15.8) 78.3 (7.8)  < 0.001 85,3 (14.6) 75.5 (9.3)  < 0.001 
BMI (kg/m2) 29.2 (5.9) 21.8 (3.1) < 0.001 26.4 (5.9)   22.2 (3.4)  < 0.001 
Waist/hip ratio 0.90 (0.08) 0.83 (0.05) < 0.001 0.82 (0.07) 0.78 (0.06) <0.001 
Waist/height ratio 0.55 (0.09) 0.44 (0.04) <0.001 0.51 (0.09)  0.46 (0.6) <0.001 
SAT  (mm) 31.0 (14.3) 12.5 (7.7)  <0.001 30.0 (14.7) 18.6 (8.6) <0.001 
VAT (mm) 41  (16.6) 34.7 (9.9) < 0.001 31.4 (9.8) 29.5 (8.7) 0.94 
Abdominal SFT (mm) 29.9  (11.1) 15.5 (8.5) < 0.001 29.2 (8.5)  23.4 (7.3) < 0.001 
Triceps SFT (mm) 20.5 (10.5) 10.0 (4.3) < 0.001 22.9 (7.5)  18.3 (5.4) < 0.001 
Subscapular SFT(mm) 22.3 (10.5) 11.0 (4.7) <0.001 20.5 (8.4)  14.7 (5.4) < 0.001 





SBP (mm Hg) 124 (10) 119 (10) < 0.001 110 (9.0) 109 (10.0) 0.30 
DBP (mm Hg) 60 (7)  59 (7) 0.37 60 (6) 60 (7) 0.85 










ALT (U/L) 39.0 (23.3) 22.0 (9.9) < 0.001 19.7 (13.3) 18.1 (10.2) 0.20 
AST (U/L) 31.3 (14.4) 27.0 (8.3) 0.001 21.3 (5.4) 22.0 ( (5.1) 0.19 
GGT (U/L) 23.6 (14.1) 15.4 (7.3)  < 0.001 13.9 (6.8) 13.0 (6.8) 0.24 
Triglycerides (mmol/L) 1.25 (0.6) 1.0 (0.6) 0.006 1.1 (0.6) 1.0 (0.5) 0.01 
HDL-C (mmol/L) 1.08 (0.18) 1.22 (0.25) <0.001 1.31 (0.28) 1.42 (0.31) 0.001 
LDL-C (mmol/L) 2.35 (0.79) 2.22 (0.64)  0.18 2.52 (0.74) 2.41(0.62) 0.13 
Glucose (mmol/L) 5.0 (0.5) 4.8 (0.7)  0.07 4.6 (0.4) 4.7 (0.4) 0.70 
Insulin (mU/L) 10.5 (6.7-19.2)  6.8 (4.4-9.9) < 0.001 9.7 (6.8-15.6) 7.5 (5.1-10.7) < 0.001 
hsCRP (mg/L)  1.1 (0.5-2.4) 0.4 (0.2-0.8) <0.001 1.3 (0.4-4.6) 0.7 (0.3-1.8) 0.001 
HOMA-IR 2.34 (1.45-4.09) 1.43 (0.94-2.13) < 0.001 2.05 (1.32-3.13) 1.53 (1.03-2.18) < 0.001 
Adiponectin (mg/L) 6.6 (2.2) 8.4 (5.2)  0.009 9.3 (4.6) 11.9 (6.4) <0.001 
Leptin (µg/L) 12.4 (6.2-28.4) 2.3 (1.4-5.2) <0.001 43.3 (27.1-66.4) 22.4 (13.9-35.8) <0.001 
 
Table 1. Characteristics of the Cohort Comparing Anthropometric, Cardiovascular, and 
Biochemical Features in Males and Females. Results are presented as means and standard 
deviations or medians and IQRs. The P values compare adolescents with NAFLD to those 
without NAFLD. Adolescents with NAFLD had significantly greater adiposity, HOMA-IR, 
serum leptin and hsCRP, but lower HDL cholesterol and adiponectin values than those without 
NAFLD. Males with NAFLD also had greater visceral adiposity, systolic blood pressure and liver 











AGE MEASUREMENT  MALE   FEMALE  
  Difference  95% CI P-value Difference  95% CI P-value 
0 
(Birth) 
Birth Weight z-score (SD) -0∙21 -0∙17,0∙58  0∙27 0∙01 -0∙28,0∙25  0∙91 
 % Expected Birth Weight -2% -2%, 5%  0∙39 1% -3, 2%  0∙53 
 Ponderal Index (kg/m3) 0∙06 -0∙92,0∙80  0∙88 -0∙25 -0∙37,0∙86  0∙43 
 Triceps SFT (mm) 0∙00  -0∙30,0∙20 0∙85 0∙00 -0∙20,0∙20  0∙77 
 Parascapular SFT (mm) 0∙00 -0∙20,0∙30  0∙88 0∙00 -0∙20,0∙30  0∙82 
 Infrascapular SFT (mm) 0∙00 -0∙20,0∙30  0∙73 0∙00 -0∙20,0∙20  0∙99 
1 Change in weight z-score birth to 
1 year 
0∙27 -0∙73,0∙18  0∙24 -0∙01 -0∙25,0∙26  0∙96 
 Chest circumference (cm) -0∙40 -1∙00,0∙20  0∙21 -0∙20 -0∙60,0∙30  0∙45 
 Arm circumference (cm)  0∙00 -0∙40,0∙30  0∙72 0∙00 -0∙30,0∙20  0∙92 
 Suprailiac SFT (mm) -0∙10 -0∙60,0∙40  0∙68 -0∙20 -0∙60,0∙20  0∙28 
3 Suprailiac SFT (mm) -1∙10 -1∙80,-0∙40  0∙002 -1∙10 -1∙60,-0∙50  0∙0002 
 Chest circumference (cm) -1∙00 -1∙80,-0∙20  0∙018 -0∙60 -1∙20,0∙00  0∙07 
 Arm circumference (cm)  -0∙50 -0∙90,-0∙10  0∙019 -0∙30 -0∙60,0∙00  0∙06 
5 Suprailiac SFT (mm) -2∙20 -3∙50,-1∙20  6∙2x10-6 -2∙40 -3∙20,-1∙50  3∙4x10-8 
 Chest circumference (cm) -2∙50 -3∙50,-1∙60  9∙0x10-8 -1∙40 -2∙20,-0∙60  0∙0003 
 Arm circumference (cm)  -1∙30 -1∙80,-0∙80  1∙2x10-6 -0∙60 -1∙00,-0∙30  0∙0008 
8 Chest circumference (cm) -4∙50 -6∙10,-3∙00  4∙9x10-9 -2∙50 -3∙70,-1∙40  1∙4x10-5 
 Arm circumference (cm) -1∙90 -2∙70,-1∙20  8∙3x10-8 -1∙10 -1∙60,-0∙60  4∙0x10-5 
10 Suprailiac SFT (mm) -10∙80 -13∙90,-7∙90  5∙5x10-13 -5∙10 -7∙00,-3∙10  9∙0x10-8 
 Arm circumference (cm) -3∙30 -4∙20,-2∙50  4∙5x10-12 -1∙40 -2∙00,-0∙80  1∙8x10-5 
14 Waist Circumference (cm) -16∙00 -19∙55,-12∙50  4∙9x10-16 -7∙50 -9∙65,-5∙40  4∙3x10-12 
 Arm circumference (cm) -4∙00 -5∙00,-3∙00  1∙2x10-13 -2∙00 -2∙50,-1∙10  2∙5x10-7 
17 Suprailiac SFT (mm) -16∙30 -19∙20,-12∙50  1∙7x10-17 -6∙95 -8∙80,-5∙10  3∙6x10-12 
 Arm circumference (cm) -5∙00 -6∙00,-4∙00  3∙0x10-16 -2∙50 -3∙20,-2∙00  2∙2x10-12 
 Waist Circumference (cm) -19∙80 -23∙35,-16∙15  1∙3x10-19 -8∙25 -10∙70,-5∙75  4∙4x10-11 
 
Table 2. Associations between anthropometry from birth to age 17 years in subjects with or 
without NAFLD diagnosed at 17 years. P-values compare NAFLD and non-NAFLD groups 
based on the Mann-Whitney U-test. Suprailiac skinfold thickness (SFT) from age 3 years 
































0  None  - - - None - - - 




































<0∙001  ↑Suprailiac SF 
(mm) 
1∙43  1∙25, 
1∙64 
<0∙001  











Table 3. Sex-specific risk of NAFLD at age 17 presented as adjusted odds ratio per 5mm increase 
in suprailiac skinfold thickness (SFT). Suprailiac skinfold thickness was consistently the 
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